KURA Financials

Kura Oncology Inc - Financial statements & key metrics

Stock Price

$9.68

Market Cap

$793.54M

EPS

$-3.18

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$53.88M

Gross Profit

Operating Income

Net Income

$-173.98M

EPS (Diluted)

$-2.02

Balance Sheet Highlights

Total Assets

$760.16M

Total Liabilities

$346.52M

Shareholders Equity

Cash & Equivalents

$224.46M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$134.32M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

-272.1%

Operating Margin

-5.0%

ROE

-0.9%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is KURA revenue?

KURA's most recent quarterly revenue was $53.88M. Annual revenue can be calculated by summing the four most recent quarters.

Is KURA profitable?

KURA reported a loss of $173.98M in the most recent quarter.

What is KURA market cap?

KURA has a market capitalization of $793.54M, making it a small-cap stock.

Does KURA have debt?

View KURA's balance sheet for debt information.

What is KURA cash flow?

Cash flow data is available in the full financial statements.